Euro Panel Products Limited (NSE:EUROBOND)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	5,694	3,859	4,008	2,634	2,715	-
Market Cap Growth	-3.73%	-3.73%	52.19%	-2.98%	-	-
Enterprise Value	6,808	4,782	4,505	3,016	3,275	-
Last Close Price	232.40	157.50	163.60	107.50	110.80	-
PE Ratio	30.90	20.94	27.43	26.13	20.74	-
PS Ratio	1.35	0.91	1.01	0.80	1.25	-
PB Ratio	4.27	2.90	3.49	2.62	3.00	-
P/TBV Ratio	4.28	2.90	3.49	2.63	3.03	-
P/FCF Ratio	45.87	31.09	222.46	26.02	-	-
P/OCF Ratio	16.71	11.32	11.59	14.84	-	-
EV/Sales Ratio	1.61	1.13	1.14	0.91	1.51	-
EV/EBITDA Ratio	16.28	11.44	14.50	11.74	12.08	-
EV/EBIT Ratio	19.39	13.62	16.31	13.60	13.80	-
EV/FCF Ratio	54.85	38.53	250.02	29.80	-	-
Debt / Equity Ratio	0.87	0.87	0.80	0.55	0.35	1.59
Debt / EBITDA Ratio	2.78	2.78	2.85	2.07	1.16	3.61
Debt / FCF Ratio	9.37	9.37	50.83	5.42	-	16.92
Asset Turnover	1.43	1.43	1.57	1.62	1.33	1.03
Inventory Turnover	1.92	1.92	2.08	2.09	1.60	1.28
Quick Ratio	0.33	0.33	0.29	0.35	0.38	0.36
Current Ratio	1.49	1.49	1.50	1.74	1.97	1.50
Return on Equity (ROE)	14.86%	14.86%	13.58%	10.57%	21.12%	11.49%
Return on Assets (ROA)	7.42%	7.42%	6.86%	6.81%	9.06%	5.36%
Return on Capital (ROIC)	9.63%	9.63%	9.55%	9.98%	14.18%	8.81%
Return on Capital Employed (ROCE)	22.40%	22.40%	20.10%	19.30%	22.30%	17.70%
Earnings Yield	3.24%	4.78%	3.65%	3.83%	4.82%	-
FCF Yield	2.18%	3.22%	0.45%	3.84%	-5.76%	-
Buyback Yield / Dilution	-0.04%	-0.04%	-	-23.86%	-9.89%	-10.92%

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.